IQVIA™ Real-World Insights Bibliography

Cost-effectiveness of cetuximab (Erbitux®) in combination with radiotherapy versus radiotherapy alone in the treatment of locally advanced head and neck cancer in France
Author(s): Brown B, Roninson P, Launois R, Griebsch I
Affiliations(s): 
Publication(s): 
Document Type(s): Poster,
Countries: France,
C:
Y:
Oncology,
2006
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Can pharmaceutical industry use reps to provide medical practice guidelines (Migraine and asthma)
Author(s): Chaix-couturier C, Benis E, Calles B, Collomb D, Anhoury P
Affiliations(s): 
Publication(s): 
Document Type(s): Oral presentation,
Countries: 
C:
Y:
Methodology,
2006
  L:
A:
English
  Add to report
 
 
Do patients with older onset rheumatoid arthritis receive less aggressive treatment than younger patients
Author(s): Tutuncu Z, Reed G, Kremer J, Kavanaugh A
Affiliations(s): 
Publication(s):  Ann Rheum Dis 2006; 65(9):1226-1229
Document Type(s): Article,
Countries: 
C:
Y:
Rheumatology,
2006
  L:
A:
English
RWLPR (Real-World Late Phase Research-quintiles,
  Add to report
 
 
Cost-effectiveness analysis of adjuvant therapy with trastuzumab (Herceptin) for the treatment of breast cancer in inicial stages.
Author(s): Polanco Sánchez C, Rodríguez Sánchez C, Sánchez-Rovira P, Barnadas Molins A, Sabater Torres FJ, Álvarez Sanz C.
Affiliations(s): 
Publication(s):  VII Scientific Meeting of the Asociación Española de Evaluación de Tecnologías Sanitarias (Spanish Association of Health Technology Evaluation), Sevilla (Spain) 16-17 November
Document Type(s): Poster,
Countries: 
C:
Y:
Oncology,
2006
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
The CORRONA database
Author(s): Kremer JM
Affiliations(s): 
Publication(s):  Autoimmun Rev. 2006; 5(1):46-54
Document Type(s): Article,
Countries: 
C:
Y:
Rheumatology,
2006
  L:
A:
English
RWLPR (Real-World Late Phase Research-quintiles,
  Add to report
 
 
Cost-effectiveness of pemetrexed plus cisplatin versus cisplatin alone in the treatment of malignant pleural mesothelioma
Author(s): Davey P, Cordony A, Rajan N, Arora B, Pavlakis N.
Affiliations(s): 
Publication(s):  ISPOR 2nd Asia-Pacific conference
ISPOR 2nd Asia-Pacific conference, Worldfield Convention Hotel, Shanghai, China
Document Type(s): Poster,
Countries: 
C:
Y:
Oncology, Respiratory disease,
2006
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Cost-effectiveness of pemetrexedplus cisplatin versus cisplatin alone in the treatment of malignant pleuralmesothelioma.
Author(s): Davey P, Cordony a, Rajan N, Arora B, Pavlakis
Affiliations(s): 
Publication(s):  ISPOR 2nd Asia-Pacific Congress,Shanghai, China
Document Type(s): Poster,
Countries: 
C:
Y:
Oncology,
2006
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
?Factors Associated with Care Seeking for Overactive Bladder Symptoms,?
Author(s): Nichol M, Brubaker L, Fanning T, Hussein M, Becker R, Benner J, Jumadilova Z,
Affiliations(s): 
Publication(s):  11th Annual Meeting of the International Society of Pharmacoeconomics and Outcomes Research, June 2006.
Document Type(s): Oral presentation,
Countries: 
C:
Y:
Overactive bladder,
2006
  L:
A:
English
  Add to report
 
 
Which patients should receive aspirin for primary prevention of cardiovascular disease? An economic evaluation.
Author(s): Annemans L, Lamotte M, Kubin M, Evers T, Verheugt FW
Affiliations(s): 
Publication(s):  Int J Clin Pract., 2006, 60(9): 1129-1137
Document Type(s): Article,
Countries: Belgium,
C:
Y:
Cardiovascular disease,
2006
  L:
A:
English
Economic evaluation,
  Add to report
 
 
A multi-country health economic evaluation of highly concentrated N-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction.
Author(s): Lamotte M, Annemans L, Kawalec P, Zoellner Y
Affiliations(s): 
Publication(s):  Pharmacoeconomics, 2006, 24(8): 783-795
Document Type(s): Article,
Countries: Belgium,
C:
Y:
Cardiovascular disease,
2006
  L:
A:
English
Economic evaluation,
  Add to report
 
 
First Page Previous Page  413 of 413